The objectives of this post-marketing surveillance (PMS) are to grasp the actual use of lamotrigine tablets to collect safety information in the long-term use according to seizure type and concomitant antiepileptic drug (AED), and to confirm its efficacy.
Study Type
OBSERVATIONAL
Enrollment
850
Administered for long-term according to the prescribing information in the locally approved label by the authorities.
The incidence of adverse drug reactions
Time frame: 1 year
Occurrence of skin disorder after the start of treatment
Presence or absence of skin disorder and its details after the start of treatment will be investigated as a priority investigation item
Time frame: 1 year
Overall improvement of subjects' symptoms
Investigators will assess the overall improvement as "remarkably improved". "improved", "slightly improved", "unchanged" or "worsened" on the basis of the degree of change in frequency of seizures, strength, span and other related symptoms.
Time frame: 1 year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.